Agios Pharmaceuticals, Inc. (AGIO)

Agios Pharmaceuticals Revenue

Agios Pharmaceuticals had revenue of $8.96M in the quarter ending September 30, 2024, with 21.15% growth. This brings the company's revenue in the last twelve months to $32.87M, up 36.79% year-over-year. In the year 2023, Agios Pharmaceuticals had annual revenue of $26.82M with 88.36% growth.

• Revenue (ttm): $32.87M
• Revenue Growth: +36.79%
• P/S Ratio: 60.90
• Revenue / Employee: $85,158
• Employees: 386
• Market Cap: 2.02B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	26.82M	12.58M	88.36%
Dec 31, 2022	14.24M	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-
Dec 31, 2019	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.